Completed PHASE3 INTERVENTIONAL 3-arm NCT02010918

Efficacy and Safety of Glucosamine Sulfate and Chondroitin Sulfate Combination in Treatment of Knee Osteoarthritis

A Phase III, Multicenter, Randomized, Parallel, Open Label and Comparative Study to Evaluate the Efficacy of 500 mg Glucosamine Sulfate (GS) / 400 mg Chondroitin Sulfate (CS)Capsules and 1500 mg GS / 1200 mg CS Sachet Compared With Cosamin DS® Capsule in Treatment of Knee Osteoarthritis..

Sponsor: Ache Laboratorios Farmaceuticos S.A.

Conditions Knee Osteoarthritis

Interventions Cosamin DS® glucosamine sulfate /chondroitin sulfate - capsules glucosamine sulfate /chondroitin sulfate - sachet

Updated 5 times since 2017 Last updated: Dec 10, 2013 Started: Feb 28, 2009 Primary completion: Nov 30, 2010 Completion: Nov 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Knee Osteoarthritis and is currently completed. Ache Laboratorios Farmaceuticos S.A. leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ache Laboratorios Farmaceuticos S.A.

Data source: Ache Laboratorios Farmaceuticos S.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Campinas, Brazil